+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase



A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase



Journal of Biological Chemistry 275(48): 37712-7



The novel transmembrane aspartic protease BACE (for Beta-site APP Cleaving Enzyme) is the beta-secretase that cleaves amyloid precursor protein to initiate beta-amyloid formation. As such, BACE is a prime therapeutic target for the treatment of Alzheimer's disease. BACE, like other aspartic proteases, has a propeptide domain that is removed to form the mature enzyme. BACE propeptide cleavage occurs at the sequence RLPR downward arrowE, a potential furin recognition motif. Here, we explore the role of furin in BACE propeptide domain processing. BACE propeptide cleavage in cells does not appear to be autocatalytic, since an inactive D93A mutant of BACE is still cleaved appropriately. BACE and furin co-localize within the Golgi apparatus, and propeptide cleavage is inhibited by brefeldin A and monensin, drugs that disrupt trafficking through the Golgi. Treatment of cells with the calcium ionophore, leading to inhibition of calcium-dependent proteases including furin, or transfection with the alpha(1)-antitrypsin variant alpha(1)-PDX, a potent furin inhibitor, dramatically reduces cleavage of the BACE propeptide. Moreover, the BACE propeptide is not processed in the furin-deficient LoVo cell line; however, processing is restored upon furin transfection. Finally, in vitro digestion of recombinant soluble BACE with recombinant furin results in complete cleavage only at the established E46 site. Taken together, our results strongly suggest that furin, or a furin-like proprotein convertase, is responsible for cleaving the BACE propeptide domain to form the mature enzyme.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045061760

Download citation: RISBibTeXText

PMID: 10956649

DOI: 10.1074/jbc.m005339200


Related references

Beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440): 735-741, 1999

Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. Journal of Neurochemistry 76(5): 1532-1539, 2001

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport 13(16): 2031-2033, 2002

Processing of beta-secretase by furin and other members of the proprotein convertase family. Journal of Biological Chemistry 276(6): 4211-4217, 2000

B-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440): 5-41, 1999

beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Brain Research. Molecular Brain Research 97(1): 103-113, 2001

Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway. Journal of Neurochemistry 73(5): 2056-2062, 1999

Identification of a novel substrate of Alzheimer's beta-secretase: beta-secretase dependent cleavage of alpha 2,6 sialyltransferase. Seikagaku. Journal of Japanese Biochemical Society 74(9): 1180-1183, 2002

Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. Brain Research. Molecular Brain Research 116(1-2): 155-158, 2003

Beta-secretase (BACE) as a drug target for Alzheimer's disease. Advanced Drug Delivery Reviews 54(12): 1589-1602, 2002

The beta-secretase, BACE: a prime drug target for Alzheimer's disease. Journal of Molecular Neuroscience 17(2): 157-170, 2002

Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease. Neurobiology of Aging 31(6): 0-925, 2010

Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. Neuroscience Letters 313(1-2): 105-107, 2001

Take Five: BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO (European Molecular Biology Organization) Journal 23(3): 483-488, 11 February, 2004

Bone morphogenetic protein-1 processes the NH2-terminal propeptide, and a furin-like proprotein convertase processes the COOH-terminal propeptide of pro-alpha1(V) collagen. Journal of Biological Chemistry 273(42): 27511-7, 1998